Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

SCAGLIONE, Rosario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.789
EU - Europa 4.571
AS - Asia 3.413
SA - Sud America 566
AF - Africa 66
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.418
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.684
IT - Italia 1.276
SG - Singapore 1.159
CN - Cina 976
RU - Federazione Russa 955
FI - Finlandia 553
BR - Brasile 451
UA - Ucraina 370
DE - Germania 364
HK - Hong Kong 357
VN - Vietnam 324
IE - Irlanda 235
PL - Polonia 214
GB - Regno Unito 179
FR - Francia 177
JP - Giappone 90
BD - Bangladesh 85
KR - Corea 85
SE - Svezia 82
IN - India 64
CA - Canada 50
TR - Turchia 50
NL - Olanda 35
AR - Argentina 34
MX - Messico 34
PK - Pakistan 28
IQ - Iraq 24
BE - Belgio 23
RO - Romania 23
ID - Indonesia 19
AT - Austria 18
CL - Cile 18
NP - Nepal 17
VE - Venezuela 17
EC - Ecuador 16
ES - Italia 15
UZ - Uzbekistan 15
ZA - Sudafrica 15
IR - Iran 13
MA - Marocco 13
MY - Malesia 13
PH - Filippine 12
AE - Emirati Arabi Uniti 11
SA - Arabia Saudita 10
CH - Svizzera 9
CI - Costa d'Avorio 9
CO - Colombia 9
AL - Albania 8
AU - Australia 7
AZ - Azerbaigian 7
BG - Bulgaria 7
IL - Israele 7
JO - Giordania 7
PY - Paraguay 7
EG - Egitto 6
MK - Macedonia 6
PE - Perù 6
AO - Angola 4
BH - Bahrain 4
BO - Bolivia 4
CR - Costa Rica 4
EU - Europa 4
GE - Georgia 4
JM - Giamaica 4
LB - Libano 4
MD - Moldavia 4
OM - Oman 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
TW - Taiwan 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
HN - Honduras 3
KE - Kenya 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LT - Lituania 3
PA - Panama 3
TN - Tunisia 3
UY - Uruguay 3
LU - Lussemburgo 2
MN - Mongolia 2
NO - Norvegia 2
SN - Senegal 2
AM - Armenia 1
BB - Barbados 1
BF - Burkina Faso 1
BY - Bielorussia 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ME - Montenegro 1
NG - Nigeria 1
Totale 16.408
Salva come PNG Salva come JPEG
Città #
Ashburn 912
Fairfield 864
Singapore 770
Woodbridge 495
Chandler 485
San Jose 399
Houston 384
Seattle 354
Wilmington 350
Hong Kong 347
Cambridge 284
Ann Arbor 283
Dublin 235
Palermo 231
Zgierz 186
Jacksonville 177
Council Bluffs 166
Beijing 158
Moscow 153
Medford 142
Des Moines 136
Ho Chi Minh City 120
Santa Clara 116
Boardman 114
Altamura 103
Nanjing 100
Los Angeles 98
New York 95
Princeton 92
Frankfurt am Main 87
Tokyo 86
Lauterbourg 84
Helsinki 79
Hanoi 75
San Diego 69
Lawrence 68
Milan 68
Dallas 59
Hefei 57
Buffalo 55
Dearborn 55
Tulsa 53
Rome 52
Hebei 49
Jinan 46
Shenyang 46
The Dalles 42
São Paulo 39
Columbus 38
Izmir 34
Nanchang 34
Tianjin 33
Phoenix 31
Changsha 30
London 29
Chicago 26
San Mateo 26
Springfield 25
Kumar 22
Naples 22
Brussels 21
Da Nang 21
Florence 21
Ottawa 21
Seongnam 20
Düsseldorf 19
Verona 19
Amsterdam 18
Auburn Hills 18
Jiaxing 18
Guangzhou 17
Ningbo 16
Orem 16
Taizhou 15
Zhengzhou 15
Atlanta 14
Baghdad 14
Falls Church 14
Munich 14
Rio de Janeiro 13
Shanghai 13
Haiphong 12
Ludwigshafen am Rhein 12
Nuremberg 12
Saint Petersburg 12
Santiago 12
Turin 12
Belo Horizonte 11
Denver 11
Grassobbio 11
Hangzhou 11
Kraków 11
Prineville 11
San Paolo di Civitate 11
Tashkent 11
Brasília 10
Mumbai 10
Taiyuan 10
Abidjan 9
Boston 9
Totale 10.433
Salva come PNG Salva come JPEG
Nome #
Obesità e rischio cardiovascolare. 578
A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha galactosidase A gene 306
Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor blocker in hypertensive patients: a 24 week randomized controlled double-dummy trial. 287
Early carotid atherosclerosis and cardiac diastolic abnormalities in hypertensive subjects 284
Safety of etanercept therapy in rheumatoid patients undergoing surgery: preliminary report. 273
A meta-analysis of the effect size of rheumatoid arthritis on left ventricular mass: comment on the article by Rudominer et al 268
Advice for health-care professionals on how to retrieve more efficiently scientifically strong and up-to-date studies on treatments by PubMed. 265
Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease. 252
Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading. 249
May Adiponectin be considered as a Novel Cardiometabolic Biomarker? 236
L’obesità fattore o co-fattore di rischio? 233
Association between low education and higher global cardiovascular risk 232
Hypoadiponectinemia, cardiometabolic comorbidities and left ventricular hypertrophy 226
Improving efficacy of PubMed Clinical Queries for retrieving scientifically strong studies on treatment. 222
Circulating adiponectin: a cardiometabolic marker associated with global cardiovascular risk 222
Fast recovery with etanercept in patients affected by polymyalgia rheumatica and decompensated diabetes: a case-series study. 218
Evidence-Based Knowledge Management: an approach to effectively promote good health-care decision-making in the Information Era. 215
Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects 214
Relationship between circulating E-selectin, DD genotype of angiotensin-converting-enzyme, and cardiovascular damage in central obese subjects 214
Plasma adiponectin: A contributing factor for cardiac changes in visceral obesity-associated hypertension 212
Surgery during etanercept therapy in patients with rheumatoid arthritis: is it time to follow patient preferences? 211
Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: an Italian case-control study. 210
The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure. 206
Effects of moderate Sicilian red wine consumption on inflammatory biomarkers of atherosclerosis. 205
Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome. 202
Cardiac involvement in rheumatoid arthritis: evidence of silent heart disease 202
Effect of dual blockade of renin-angiotensin system on TGF beta 1 and left ventricular structure and function in hypertensive patients 200
Education and hypertension: impact on global cardiovascular risk 197
Right ventricular diameter predicts all-cause mortality in heart failure with preserved ejection fraction 196
Visceral obesity and metabolic syndrome: two faces of the same medal? 194
Central obesity and hypertensive renal disease: association between higher levels of BMI, circulating transforming growth factor beta1 and urinary albumin excretion. 194
Lymphocyte beta-adrenergic receptors in young subjects with peripheral or central obesity: relationship with central haemodynamics and left ventricular function 193
Effects of cilazapril on renal haemodynamics and function in hypertensive patients: a randomised controlled study versus hydrochlorothiazide 193
Optimized search strategy for detecting scientifically strong studies on treatment through PubMed 192
Cardiovascular Events in Rheumatoid Arthritis - Time to See beyond Articular Involvement in "real World" Clinical Practice: Comment on the Article by Mackey et al 192
Effetti cardioprotettivi del Blocco del Sistema Renina-Angiotensina-Aldosterone tramite l’associazione ACE-inibitore – Sartani: Relazione con i livelli circolanti di Transforming Growth Factor ß1. 191
The Relationship between the Transforming Growth Factor β1 T29C Gene Polymorphism and Left Ventricular Geometry and Function in Hypertensive Subjects 188
Hemostatic function in young subjects with central obesity: relationship with left ventricular function 188
Antihypertensive efficacy and effects of nitrendipine on cardiac and renal hemodynamics in mild to moderate hypertensive patients: randomized controlled trial versus hydrochlorothiazide. 188
Echo-Doppler left ventricular filling abnormalities in patients with rheumatoid arthritis without clinically evident cardiovascular disease 186
Associazione tra elevate livelli circolanti di Transforming growth factor ß1 (TGF ß1) ed alterato riempimento ventricolare sinistro in una popolazione di soggetti ipertesi. 184
Association between reduced lymphocyte beta-adrenergic receptors and left ventricular dysfunction in young obese subjects 182
Polymyalgia rheumatica and vertebral fractures: a 1-year pilot controlled study 180
Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function 178
Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities. 178
DIASTOLIC DYSFUNCTION AND CENTRAL OBESITY RELATED HYPERTENSION: ROLE OF TRASFORMING GROWTH FACTOR BETA-1 177
Central obesity and hypertension: the role of plasma endothelin. Am J Hypertens 175
Heart involvement in Rheumatoid Arthritis: Systematic review and meta-analysis. 171
Rapid left ventricular filling in untreated hypertensive subjects with or without left ventricular hypertrophy 171
Methodological matters on an Alzheimer's dementia trial: is a double-blind randomized controlled study design sufficient to draw strong conclusions on treatment? 169
Analysis of 24-h noninvasive ambulatory blood pressure profiles by a third-degree polynomial approach 168
Evidence-based practice needs stronger prognostic scores for the prediction of recurrent stroke. 167
DIASTOLIC DYSFUNCTION AND CENTRAL OBESITY RELATED HYPERTENSION: ROLE OF TRANSFORMING GROWTH FACTOR BETA-1 165
Ultrasonography NAFLD subclinical carotid atherosclerosis and inflammatory markers in patients with and without metabolic syndome. 163
Associazione tra elevati livelli circolanti di Transforming growth factor ß1 (TGF ß1) e alterato riempimento ventricolare sinistro in una popolazione di soggetti ipertesi. 161
No evidence-based practice by biased information from systematic reviews: the case of etanercept and infliximab for the treatment of psoriatic arthritis. 161
Heredity and obesity-associated hypertension: impact of hormonal characteristics and left ventricular mass. J Hypertens 161
Vascular health in subjects with rheumatoid arthritis: assessment of endothelial function indices and serum biomarkers of vascular damage 159
Obesity and cardiovascular risk: the new public health problem of worldwide proportions. 158
Sindrome metabolica oggi: che cosa c’è da sapere, che cosa c’è da fare. 157
Two-dimensional echocardiographic evaluation of left ventricular ejection fraction by the ellipsoid single-plane algorithm: a reliable method for assessing low or very low ejection fraction values? 157
Effetti a lungo termine del trattamento con Simvastatina ed Ezetimibe sui livelli di HDL-C e hs-PCR in pazienti affetti da Ipercolesterolemia familare(FH) con pregresso IMA e/o Lesione carotidea 151
Evaluation of regional haemodynamics and alterations of vascu¬lar wall of the lower limbs in hypertensive subjects 150
Obesity, hypertension and atherosclerosis 150
Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia 150
Obesity: a main factor of metabolic syndrome? 148
Efficacia della associazione Atorvastatina e n-3 PUFA in pazienti affetti da dislipidemia combinata e ad alto rischio di eventi cardiovascolari 148
Haemostatic and fibrinolytic abnormalities in obese patients and in patients with type 2 diabetes with metabolic syndrome 147
Effects of amlodipine on renal haemodynamics in mild to moderate hypertensive patients. A randomized controlled study versus placebo. Eur J Clin Pharmacol 147
Left ventricular diastolic filling alterations in subjects with mitral valve prolapse: a Doppler echocardiographic study 147
Non-alcoholic fatty liver disease: Severity of fibrosis and its relationships with clinical and biological variables 147
Left ventricular function response to exercise in normotensive obese subjects: influence of degree and duration of obesity. 146
Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial 144
Prevalence of obesity and ischaemic heart disease in hypertensive subjects 133
Nutrizione,sovrappeso e sindrome metabolica 130
Salt-regulating hormones in young normotensive obese subjects. Effects of saline load. 129
Effects of a short-term hypoenergetic diet on morphofunctional left ventricular parameters in centrally obese subjects 128
Left ventricular diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity. 125
Obesità, Diabete e Rischio Cardiovascolare. 123
Micro-albuminuria in obese subjects: relationship among body fat distribution, blood pressure and left ventricular structure and function. 118
Obesity and cardiovascular diseases. 117
Iperuricemia: significato clinico e nuove prospettive di trattamento 116
Sindrome Metabolica 114
La terapia dietetica nell’insufficienza renale cronica. 110
Sindrome metabolica: fatti e compromessi. 107
Scompenso cardiaco da disfunzione diastolica. 104
Transforming growth factor beta1 ed effetto nefroprotettivo dell’associazione ACE-inibitori-AT1 antagonista in soggetti ipertesi con iniziale danno renale 103
Therapeutic management of elderly hypertensives with concomitant ischaemic heart disease. 91
Prevalence of pericardial effusion in subjects with rheumatoid arthritis: an echocardiographic study 89
Transforming growth factor β1 T29C gene polymorphism and hypertension: Relationship with cardiovascular and renal damage 88
Transforming growth factor β1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: A 24-week randomized controlled trial 85
Pathogenetic Mechanisms of Hypertension–Brain-Induced Complications: Focus on Molecular Mediators 79
Effect of obesity on left ventricular function studied by radionuclide angiocardiography. 77
Il paziente iperteso ad alto rischio cadiovascolare 76
Transforming growth factor ß1 ed effetto nefroprotettivo dell’associazione ACE-inibitore/ AT1 antagonista in soggetti ipertesi con iniziale danno renale. 74
null 51
null 42
Totale 16.860
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.961
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021139 0 0 0 0 0 0 0 0 0 0 0 139
2021/20221.162 37 298 20 49 36 33 81 55 133 144 90 186
2022/20231.469 126 279 34 145 158 222 115 100 173 15 60 42
2023/2024585 31 85 30 37 43 105 41 43 8 14 17 131
2024/20251.567 34 122 70 172 45 37 92 101 114 175 202 403
2025/20265.651 391 140 269 399 472 869 913 650 366 816 287 79
Totale 16.860